Brightcom Group Ltd - 532368 - Compliance Certificate For The Half Year Ended 31St March 2020
We are enclosing a Compliance Certificate under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended 31st March 2020. Brightcom Group Ltd - 532368 - Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Half Year Ended 31.03.2020.
With reference to the subject cited above, please find the enclosed Practicing Company Secretary Certificate as per Regulation 40 (9) of SEBI (LODR) Regulations, 2015 for the half year ended 30.09.2019. Please update the above disclosed information in your records. Brightcom Group Ltd - 532368 - Shareholding for the Period Ended March 31, 2020
Brightcom Group Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here Battling Covid-19: India to try BCG vaccine on humans within next two weeks
The 100-yr old vaccine has an established safety profile; if effective can hit the market within this year Brightcom Group Ltd - 532368 - Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- M MANOHARDesignation :- Company Secretary and Compliance Officer
ICMR will conduct study to find effectiveness of BCG vaccine against COVID-19
Head of Epidemiology and Communicable diseases at the Indian Council of Medical Research (ICMR) Dr Raman R Gangakhedkar said that the apex health research body will begin a study on the effectiveness of the vaccine against coronavirus infection next week. Seven major consultancies join hands with Invest India for economic revival post Covid-19
Seven of the top global consultancy firms Bain & Co, EY, PwC, BCG, KPMG, Primus Partners and Mirae Asset Management have joined hand with Inv Serum's covid arsenal gets fortified with different candidates
Serum Institute of India has not one but two vaccine candidates in its arsenal against the novel coronavirus (Covid-19). And this, even as its BCG va Brightcom Group Ltd - 532368 - Closure of Trading Window
This is to inform you that pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended by SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2019, the Trading Window for dealing in the securities of the Company will be closed for designated persons including promoters, directors, key managerial personnel, employees, connected persons and their immediate relatives with effect from April 01, 2020 till 48 hours after the declaration of the Audited Financial Results of the Company for the Fourth Quarter and Financial Year ending on March 31, 2020. The date of Board Meeting for declaration of Financial Results of the Company for the Fourth Quarter and Financial Year ending on March 31, 2020 will be intimated in due course. Brightcom Group Ltd - 532368 - Update on Analyst/Investor meet & call
Brightcom Group Ltd has informed BSE regarding "Update on Analyst/Investor meet & call"